Selective oestrogen receptor modulationmolecular pharmacology for the millennium

A. S. Levenson; V. C. Jordan

doi:10.1016/S0959-8049(99)00183-5

Selective oestrogen receptor modulationmolecular pharmacology for the millennium

A. S. Levenson, V. C. Jordan

Research output: Contribution to journal › Article › peer-review

124 Scopus citations

Abstract

Knowledge of the mechanism of action and pharmacology of tamoxifen and raloxifene, for the prevention of breast cancer and osteoporosis respectively, has opened the door for the discovery of multifunctional medicines. There is now the potential to prevent osteoporosis, coronary heart disease, breast and endometrial cancer in postmenopausal women with elevated risk factors. Copyright (C) 1999 Elsevier Science Ltd.

Original language	English (US)
Pages (from-to)	1628-1639
Number of pages	12
Journal	European Journal of Cancer
Volume	35
Issue number	12
DOIs	https://doi.org/10.1016/S0959-8049(99)00183-5
State	Published - Nov 1999
Externally published	Yes

Keywords

Breast cancer
Prevention
Raloxifene
Tamoxifen

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/S0959-8049(99)00183-5

Cite this

@article{c00d2c540fa840c59e7a4fe90a0e1a59,

title = "Selective oestrogen receptor modulationmolecular pharmacology for the millennium",

abstract = "Knowledge of the mechanism of action and pharmacology of tamoxifen and raloxifene, for the prevention of breast cancer and osteoporosis respectively, has opened the door for the discovery of multifunctional medicines. There is now the potential to prevent osteoporosis, coronary heart disease, breast and endometrial cancer in postmenopausal women with elevated risk factors. Copyright (C) 1999 Elsevier Science Ltd.",

keywords = "Breast cancer, Prevention, Raloxifene, Tamoxifen",

author = "Levenson, {A. S.} and Jordan, {V. C.}",

year = "1999",

month = nov,

doi = "10.1016/S0959-8049(99)00183-5",

language = "English (US)",

volume = "35",

pages = "1628--1639",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "12",

}

TY - JOUR

T1 - Selective oestrogen receptor modulationmolecular pharmacology for the millennium

AU - Levenson, A. S.

AU - Jordan, V. C.

PY - 1999/11

Y1 - 1999/11

N2 - Knowledge of the mechanism of action and pharmacology of tamoxifen and raloxifene, for the prevention of breast cancer and osteoporosis respectively, has opened the door for the discovery of multifunctional medicines. There is now the potential to prevent osteoporosis, coronary heart disease, breast and endometrial cancer in postmenopausal women with elevated risk factors. Copyright (C) 1999 Elsevier Science Ltd.

AB - Knowledge of the mechanism of action and pharmacology of tamoxifen and raloxifene, for the prevention of breast cancer and osteoporosis respectively, has opened the door for the discovery of multifunctional medicines. There is now the potential to prevent osteoporosis, coronary heart disease, breast and endometrial cancer in postmenopausal women with elevated risk factors. Copyright (C) 1999 Elsevier Science Ltd.

KW - Breast cancer

KW - Prevention

KW - Raloxifene

KW - Tamoxifen

UR - http://www.scopus.com/inward/record.url?scp=0033379037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033379037&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(99)00183-5

DO - 10.1016/S0959-8049(99)00183-5

M3 - Article

C2 - 10674006

AN - SCOPUS:0033379037

SN - 0959-8049

VL - 35

SP - 1628

EP - 1639

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 12

ER -

Selective oestrogen receptor modulationmolecular pharmacology for the millennium

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this